Brandon James Sumpio, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Diabetic Foot | 5 | 2023 | 355 | 1.750 |
Why?
|
Peripheral Arterial Disease | 10 | 2021 | 1188 | 0.980 |
Why?
|
Venous Insufficiency | 2 | 2021 | 103 | 0.880 |
Why?
|
Endovascular Procedures | 12 | 2023 | 1979 | 0.810 |
Why?
|
Ultrasonography, Doppler, Duplex | 2 | 2021 | 205 | 0.760 |
Why?
|
Blood Vessel Prosthesis Implantation | 6 | 2023 | 1390 | 0.610 |
Why?
|
Ischemia | 7 | 2021 | 1907 | 0.570 |
Why?
|
Diabetes Mellitus | 3 | 2023 | 5751 | 0.530 |
Why?
|
Lower Extremity | 2 | 2021 | 1158 | 0.530 |
Why?
|
Vascular Grafting | 3 | 2021 | 142 | 0.500 |
Why?
|
Wound Healing | 7 | 2023 | 2785 | 0.480 |
Why?
|
Bandages | 2 | 2023 | 266 | 0.450 |
Why?
|
Vascular Surgical Procedures | 5 | 2021 | 1475 | 0.450 |
Why?
|
Amputees | 1 | 2013 | 75 | 0.440 |
Why?
|
Aortic Aneurysm, Abdominal | 4 | 2023 | 1186 | 0.420 |
Why?
|
Upper Extremity | 1 | 2016 | 648 | 0.390 |
Why?
|
Postoperative Care | 2 | 2019 | 1486 | 0.390 |
Why?
|
Molecular Imaging | 1 | 2016 | 828 | 0.330 |
Why?
|
Graft Occlusion, Vascular | 2 | 2021 | 549 | 0.310 |
Why?
|
Tibia | 1 | 2013 | 1077 | 0.300 |
Why?
|
Negative-Pressure Wound Therapy | 2 | 2019 | 150 | 0.290 |
Why?
|
Diabetes Mellitus, Experimental | 2 | 2023 | 1116 | 0.280 |
Why?
|
Intermittent Claudication | 2 | 2019 | 309 | 0.270 |
Why?
|
Aortic Diseases | 2 | 2022 | 742 | 0.260 |
Why?
|
Skin | 2 | 2023 | 4364 | 0.240 |
Why?
|
Endothelium, Vascular | 1 | 2016 | 4456 | 0.230 |
Why?
|
Raynaud Disease | 1 | 2023 | 74 | 0.210 |
Why?
|
Scleroderma, Localized | 1 | 2023 | 79 | 0.210 |
Why?
|
Therapies, Investigational | 1 | 2023 | 112 | 0.210 |
Why?
|
Mesenteric Veins | 1 | 2021 | 89 | 0.190 |
Why?
|
Thrombelastography | 1 | 2022 | 164 | 0.180 |
Why?
|
Debridement | 1 | 2022 | 492 | 0.180 |
Why?
|
Ulcer | 1 | 2021 | 209 | 0.180 |
Why?
|
Endarterectomy | 1 | 2020 | 195 | 0.180 |
Why?
|
Sclerotherapy | 1 | 2021 | 175 | 0.180 |
Why?
|
Scleroderma, Systemic | 1 | 2023 | 323 | 0.170 |
Why?
|
Retrospective Studies | 20 | 2023 | 77449 | 0.160 |
Why?
|
Popliteal Artery | 1 | 2020 | 317 | 0.160 |
Why?
|
Patient Readmission | 3 | 2023 | 3114 | 0.160 |
Why?
|
Mesenteric Vascular Occlusion | 1 | 2018 | 97 | 0.150 |
Why?
|
Thrombosis | 2 | 2022 | 2968 | 0.150 |
Why?
|
Pulsatile Flow | 1 | 2018 | 332 | 0.150 |
Why?
|
Spectrum Analysis | 2 | 2016 | 454 | 0.150 |
Why?
|
Coronary Artery Disease | 1 | 2016 | 6487 | 0.140 |
Why?
|
Femoral Artery | 1 | 2020 | 845 | 0.140 |
Why?
|
Oxyhemoglobins | 1 | 2016 | 216 | 0.130 |
Why?
|
Treatment Outcome | 17 | 2023 | 63114 | 0.130 |
Why?
|
Hyperemia | 1 | 2016 | 225 | 0.130 |
Why?
|
Thoracic Surgical Procedures | 1 | 2019 | 342 | 0.130 |
Why?
|
Brachial Artery | 1 | 2016 | 369 | 0.120 |
Why?
|
Anti-Bacterial Agents | 2 | 2023 | 7181 | 0.120 |
Why?
|
Nephrotic Syndrome | 1 | 2018 | 389 | 0.120 |
Why?
|
Risk Assessment | 9 | 2021 | 23338 | 0.120 |
Why?
|
Benchmarking | 1 | 2020 | 1042 | 0.120 |
Why?
|
Time Factors | 12 | 2021 | 40075 | 0.120 |
Why?
|
Risk Factors | 16 | 2023 | 72290 | 0.110 |
Why?
|
Quality Indicators, Health Care | 2 | 2021 | 1831 | 0.110 |
Why?
|
Perfusion Imaging | 1 | 2014 | 195 | 0.110 |
Why?
|
Celiac Artery | 2 | 2023 | 69 | 0.110 |
Why?
|
Mechanotransduction, Cellular | 1 | 2018 | 541 | 0.110 |
Why?
|
Artificial Limbs | 1 | 2014 | 123 | 0.110 |
Why?
|
Prosthesis Design | 2 | 2022 | 2110 | 0.110 |
Why?
|
Humans | 35 | 2023 | 744343 | 0.100 |
Why?
|
Vasodilation | 1 | 2016 | 944 | 0.100 |
Why?
|
Knee | 1 | 2013 | 274 | 0.100 |
Why?
|
Neovascularization, Physiologic | 1 | 2019 | 1351 | 0.100 |
Why?
|
Microcirculation | 1 | 2016 | 1286 | 0.100 |
Why?
|
Hospital Costs | 1 | 2018 | 985 | 0.100 |
Why?
|
Patient Admission | 1 | 2019 | 1380 | 0.100 |
Why?
|
Comorbidity | 6 | 2022 | 10388 | 0.100 |
Why?
|
Oxygen | 1 | 2023 | 4189 | 0.100 |
Why?
|
Foot | 1 | 2014 | 527 | 0.100 |
Why?
|
Hospital Mortality | 3 | 2019 | 5317 | 0.090 |
Why?
|
Aged, 80 and over | 10 | 2021 | 57776 | 0.090 |
Why?
|
Aged | 17 | 2023 | 163280 | 0.090 |
Why?
|
Male | 22 | 2023 | 350118 | 0.090 |
Why?
|
Hemoglobins | 1 | 2016 | 1534 | 0.090 |
Why?
|
Databases, Factual | 6 | 2021 | 7729 | 0.090 |
Why?
|
Regional Blood Flow | 3 | 2019 | 1525 | 0.090 |
Why?
|
Critical Illness | 5 | 2021 | 2670 | 0.090 |
Why?
|
Female | 22 | 2023 | 380194 | 0.090 |
Why?
|
Surgical Wound Infection | 1 | 2019 | 1540 | 0.080 |
Why?
|
Phosphoproteins | 1 | 2018 | 2440 | 0.080 |
Why?
|
Leg | 1 | 2014 | 1116 | 0.080 |
Why?
|
Limb Salvage | 2 | 2021 | 433 | 0.080 |
Why?
|
Postoperative Period | 1 | 2013 | 1842 | 0.080 |
Why?
|
Constriction, Pathologic | 2 | 2023 | 1107 | 0.080 |
Why?
|
Length of Stay | 2 | 2018 | 6309 | 0.080 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2018 | 2916 | 0.080 |
Why?
|
Health Care Costs | 1 | 2021 | 3209 | 0.070 |
Why?
|
Pilot Projects | 2 | 2019 | 8324 | 0.070 |
Why?
|
Blood Vessel Prosthesis | 2 | 2022 | 933 | 0.070 |
Why?
|
Middle Aged | 11 | 2021 | 213383 | 0.070 |
Why?
|
Stents | 1 | 2018 | 3280 | 0.070 |
Why?
|
Atherosclerosis | 1 | 2021 | 3445 | 0.060 |
Why?
|
Equipment Design | 1 | 2013 | 3582 | 0.060 |
Why?
|
Postoperative Complications | 3 | 2023 | 15295 | 0.060 |
Why?
|
United States | 9 | 2023 | 69872 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7279 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2016 | 15076 | 0.060 |
Why?
|
Angiography | 2 | 2021 | 1639 | 0.060 |
Why?
|
Streptozocin | 1 | 2023 | 196 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15540 | 0.050 |
Why?
|
Lactates | 1 | 2023 | 432 | 0.050 |
Why?
|
Elastomers | 1 | 2022 | 71 | 0.050 |
Why?
|
Remission, Spontaneous | 1 | 2021 | 382 | 0.050 |
Why?
|
Swine | 2 | 2022 | 5917 | 0.050 |
Why?
|
Platelet Function Tests | 1 | 2022 | 270 | 0.050 |
Why?
|
Prevalence | 3 | 2022 | 15226 | 0.050 |
Why?
|
Swine, Miniature | 1 | 2022 | 961 | 0.050 |
Why?
|
Aortography | 1 | 2021 | 437 | 0.040 |
Why?
|
Budgets | 1 | 2021 | 229 | 0.040 |
Why?
|
Vascular Patency | 1 | 2021 | 886 | 0.040 |
Why?
|
Hospital Bed Capacity | 1 | 2020 | 214 | 0.040 |
Why?
|
Saphenous Vein | 1 | 2021 | 532 | 0.040 |
Why?
|
Heart Diseases | 1 | 2011 | 2788 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2016 | 21746 | 0.040 |
Why?
|
Age Factors | 3 | 2021 | 18370 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2016 | 19905 | 0.040 |
Why?
|
Splanchnic Circulation | 1 | 2018 | 110 | 0.040 |
Why?
|
Ankle Brachial Index | 1 | 2018 | 154 | 0.040 |
Why?
|
Acute Disease | 2 | 2018 | 7149 | 0.040 |
Why?
|
Hematoma | 1 | 2022 | 758 | 0.040 |
Why?
|
Cell Shape | 1 | 2018 | 375 | 0.040 |
Why?
|
Abdominal Pain | 1 | 2023 | 1063 | 0.030 |
Why?
|
Prospective Studies | 2 | 2022 | 53288 | 0.030 |
Why?
|
Sex Factors | 2 | 2021 | 10397 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 25043 | 0.030 |
Why?
|
Blood Gas Monitoring, Transcutaneous | 1 | 2014 | 34 | 0.030 |
Why?
|
Registries | 2 | 2021 | 8089 | 0.030 |
Why?
|
Disease Progression | 2 | 2022 | 13284 | 0.030 |
Why?
|
Polymers | 1 | 2022 | 1621 | 0.030 |
Why?
|
Hypothyroidism | 1 | 2020 | 658 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2023 | 2382 | 0.030 |
Why?
|
Laser-Doppler Flowmetry | 1 | 2014 | 242 | 0.030 |
Why?
|
Prognosis | 3 | 2021 | 29063 | 0.030 |
Why?
|
Chronic Disease | 2 | 2021 | 9146 | 0.030 |
Why?
|
Diet | 1 | 2011 | 7939 | 0.030 |
Why?
|
Cytoskeleton | 1 | 2018 | 1185 | 0.030 |
Why?
|
Stress, Mechanical | 1 | 2018 | 1686 | 0.030 |
Why?
|
Cost Savings | 1 | 2018 | 926 | 0.030 |
Why?
|
Models, Animal | 1 | 2019 | 2171 | 0.030 |
Why?
|
Neoplasms | 1 | 2021 | 21683 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2013 | 39050 | 0.030 |
Why?
|
Tomography, Emission-Computed | 1 | 2014 | 1144 | 0.020 |
Why?
|
Mice | 3 | 2023 | 81183 | 0.020 |
Why?
|
Wine | 1 | 2011 | 165 | 0.020 |
Why?
|
Cost of Illness | 1 | 2021 | 1859 | 0.020 |
Why?
|
Adult | 4 | 2020 | 214055 | 0.020 |
Why?
|
Propensity Score | 1 | 2018 | 1781 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 2014 | 1423 | 0.020 |
Why?
|
Heparin | 1 | 2018 | 1637 | 0.020 |
Why?
|
Cacao | 1 | 2011 | 98 | 0.020 |
Why?
|
Down-Regulation | 1 | 2018 | 3002 | 0.020 |
Why?
|
France | 1 | 2011 | 517 | 0.020 |
Why?
|
Tea | 1 | 2011 | 275 | 0.020 |
Why?
|
Asia | 1 | 2011 | 610 | 0.020 |
Why?
|
Animals | 4 | 2023 | 168757 | 0.020 |
Why?
|
Thrombolytic Therapy | 1 | 2018 | 2161 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2018 | 2107 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2020 | 8642 | 0.020 |
Why?
|
Young Adult | 3 | 2020 | 56430 | 0.020 |
Why?
|
Linear Models | 1 | 2018 | 5952 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2019 | 1797 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2021 | 7785 | 0.020 |
Why?
|
Phosphorylation | 1 | 2018 | 8436 | 0.020 |
Why?
|
Adolescent | 3 | 2020 | 85781 | 0.020 |
Why?
|
Beverages | 1 | 2011 | 820 | 0.020 |
Why?
|
Quality Improvement | 1 | 2021 | 3749 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2021 | 3158 | 0.020 |
Why?
|
Odds Ratio | 1 | 2018 | 9849 | 0.020 |
Why?
|
Acute Kidney Injury | 1 | 2018 | 1972 | 0.020 |
Why?
|
Cost-Benefit Analysis | 1 | 2018 | 5391 | 0.020 |
Why?
|
Patient Discharge | 1 | 2018 | 3313 | 0.020 |
Why?
|
Ethanol | 1 | 2011 | 1342 | 0.020 |
Why?
|
Diet, Mediterranean | 1 | 2011 | 700 | 0.020 |
Why?
|
Health Status | 1 | 2018 | 4034 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12245 | 0.010 |
Why?
|
Fatty Acids | 1 | 2011 | 1809 | 0.010 |
Why?
|
Survival Rate | 1 | 2018 | 12788 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2018 | 12354 | 0.010 |
Why?
|
Logistic Models | 1 | 2018 | 13408 | 0.010 |
Why?
|
Anticoagulants | 1 | 2018 | 4599 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 20947 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2018 | 19229 | 0.010 |
Why?
|
Transcription Factors | 1 | 2018 | 12208 | 0.010 |
Why?
|
Cohort Studies | 1 | 2021 | 40561 | 0.010 |
Why?
|
Child | 1 | 2018 | 77709 | 0.010 |
Why?
|